FluWatch report: August 30 to September 12, 2015 (Week 35-36)

Overall Summary

  • This is the first report of the 2015-16 season
  • Overall, there is low influenza activity in Canada; however, influenza activity and detections are increasing in the Western provinces.
  • In weeks 35 and 36, there was one hospitalization reported.
  • For more information on the flu, see our Influenza (flu) web page.

Are you a primary health care practitioner (General Practitioner, Nurse Practitioner or Registered Nurse) interested in becoming a FluWatch sentinel for the 2015-16 influenza season? Contact us at FluWatch@phac-aspc.gc.ca

On this page

Influenza/Influenza-like Illness Activity (geographic spread)

In week 36, sporadic influenza activity was reported in the Western provinces and parts of Central and Atlantic Canada. The majority of activity was reported in the Western provinces (BC and AB), which is similar to what was reported in the laboratory detections.

Download the alternative format
(PDF format, 857 KB, 7 pages)

Organization:
Date published: 2015-09-18

Figure 1. Map of overall influenza/ILI activity level by province and territory, Canada, Week 36

Figure 1
Figure 1 Legend

Note: Influenza/ILI activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates and reported outbreaks. Please refer to detailed definitions at the end of the report. Maps from previous weeks, including any retrospective updates, are available on the Flu Activity website.

Figure 1 - Text Description
In week 36, sporadic influenza activity was reported in the Western provinces and parts of Central and Atlantic Canada. The majority of activity was reported in the Western provinces (BC and AB), which is similar to what was reported in the laboratory detections.

Laboratory Confirmed Influenza Detections

Influenza detections remain at inter-seasonal levels in week 36, with 1.2% of tests positive for influenza (Figure 2).

Figure 2. Number of positive influenza tests and percentage of tests positive, by type, subtype and report week, Canada, 2015-16

Figure 2
Figure 2 - Text Description

Influenza detections remain at inter-seasonal levels in week 36, with 1.2% of tests positive for influenza.

Most jurisdictions have reported only sporadic numbers of influenza detections in recent weeks. Influenza detections have picked up in the west, with BC and AB accounting for 82% of influenza detections in Canada in week 36. The majority of detections in Canada have been influenza A (88%) and 100% of those subtyped have been A(H3N2).

Figure 3. Cumulative numbers of positive influenza specimens by type/subtype and province, Canada, 2015-16

Figure 3

Note: Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.

Figure 3 - Text Description
Table Figure 3: Cumulative numbers of positive influenza specimens by type/subtype and province, Canada, 2015-16
Reporting provincesTable Figure 3 - Footnote 1 Weekly (September 6 to September 12, 2015) Cumulative (August 30 to September 12, 2015)
Influenza A B Influenza A B A & B Total
A Total A(H1)pdm09 A(H3) ATable Figure 3 - Footnote UnS B Total A Total A(H1)pdm09 A(H3) ATable Figure 3 - Footnote UnS B Total
BC 10 0 7 3 0 12 0 8 4 1 13
AB 4 0 1 3 0 5 0 2 3 0 5
SK 0 0 0 0 0 0 0 0 0 0 0
MB 0 0 0 0 0 0 0 0 0 0 0
ON 0 0 0 0 0 0 0 0 0 1 1
QC 2 0 0 2 0 4 0 0 4 1 5
NB 0 0 0 0 0 0 0 0 0 0 0
NS 0 0 0 0 0 0 0 0 0 0 0
PE 0 0 0 0 0 0 0 0 0 0 0
NL 1 0 0 1 0 1 0 0 1 0 1
YT 0 0 0 0 0 0 0 0 0 0 0
NT 0 0 0 0 0 0 0 0 0 0 0
NU 0 0 0 0 0 0 0 0 0 0 0
Canada 17 0 8 9 0 22 0 10 12 3 25
Percentage Table Figure 3 - Footnote 2 100.0% 0.0% 47.1% 52.9% 0.0% 88.0% 0.0% 45.5% 54.5% 12.0% 100.0%
Table Figure 3 - Footnote 1

Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Cumulative data includes updates to previous weeks.

Return to Table Figure 3 - Footnote 1 referrer

Table Figure 3 - Footnote 2

Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.

Return to Table Figure 3 - Footnote 2 referrer

Table Figure 3 - Footnote UnS

Unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.

Return to Table Figure 3 - Footnote UnS referrer

Among cases with reported age, the largest proportion was in those ≥65 years of age (45%) (Table 1).

Table 1. Weekly and cumulative numbers of positive influenza specimens by type, subtype and age-group reported through case-based laboratory reportingTable 1 - Footnote 1, Canada, 2015-16
Age groups (years) Weekly (September 6 to September 12, 2015) Cumulative (August 30 to September 12, 2015)
Influenza A B Influenza A B Influenza A and B
A Total A(H1) pdm09 A(H3) A Table 1 - Footnote UnS Total A Total A(H1) pdm09 A(H3) A Table 1 - Footnote UnS Total # %
<5 0 0 0 0 0 0 0 0 0 0 0 0.0%
5-19 2 0 1 1 0 3 0 1 2 1 4 18.2%
20-44 3 0 0 3 0 3 0 0 3 0 3 13.6%
45-64 2 0 0 2 0 5 0 2 3 0 5 22.7%
65+ 7 0 4 3 0 9 0 6 3 1 10 45.5%
Unknown 0 0 0 0 0 0 0 0 0 0 0 0.0%
Total 14 0 5 9 0 20 0 9 11 2 22 100.0%
PercentageTable 1 - Footnote 2 100.0% 0.0% 35.7% 64.3% 0.0% 90.9% 0.0% 45.0% 55.0% 9.1%    
Table 1 - Footnote 1

Table 1 includes specimens for which demographic information was reported. These represent a subset of all positive influenza cases reported.

Return to Table 1 - Footnote 1 referrer

Table 1 - Footnote 2

Percentage of tests positive for sub-types of influenza A are a percentage of all influenza A detections.

Return to Table 1 - Footnote 2 referrer

Table 1 - Footnote UnS

Unsubtyped: The specimen was typed as influenza A, but no result for subtyping was available.

Return to Table 1 - Footnote UnS referrer

For additional data on other respiratory virus detections see the Respiratory Virus Detections in Canada Report on the Public Health Agency of Canada website.

Influenza-like Illness Consultation Rate

The national influenza-like-illness (ILI) consultation rate decreased from 15.8 consultations per 1,000 patient visits in week 35 to 8.4 per 1,000 visits in week 36. In week 36, the highest ILI consultation rate was found in the 20-64 age group and the lowest was found in the 0-4 age group (Figure 4).

Figure 4. Influenza-like-illness (ILI) consultation rates by age group and week, Canada, 2015-16

Figure 4

Delays in the reporting of data may cause data to change retrospectively. In BC, AB, and SK, data is compiled by a provincial sentinel surveillance program for reporting to FluWatch. Not all sentinel physicians report every week.

Figure 4 - Text Description

Influenza-like illness consultation rate by age-group in week 36 for the 2015-16 season: Age 0-4: 0.75; Age 5-19: 6.88; Age 20-64: 10.37; Age 65+: 3.86

Influenza Outbreak Surveillance

In weeks 35 and 36, no new outbreaks of influenza were reported.

Figure 5. Overall number of new laboratory-confirmed influenza outbreaksFigure 5 - Footnote 1 by report week, Canada, 2015-2016

Figure 5
Figure 5 - Text Description
Report week Hospitals Long Term Care Facilities Other
35 0 0 0
36 0 0 0

Sentinel Pediatric Hospital Influenza Surveillance

Paediatric Influenza Hospitalizations and Deaths (IMPACT)

No laboratory-confirmed influenza-associated paediactric (≤16 years of age) hospitalizations have been reported by the Immnuzation Monitoring Program ACTive (IMPACT) network for the 2015-16 season.

Figure 6. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada, 2015-16, Paediatric hospitalizations (≤16 years of age, IMPACT)

Figure 6
Figure 6 - Text Description
Age-group (years) Hospitalizations (n=0) ICU Admissions (n=0)
0-5m 0.0% 0.0%
6-23m 0.0% 0.0%
2-4y 0.0% 0.0%
5-9y 0.0% 0.0%
10-16y 0.0% 0.0%

Figure 7. Number of cases of influenza reported by sentinel hospital networks, by week, Canada, 2015-16 Paediatric hospitalizations (≤16 years of age, IMPACT)

Figure 7

Note: The number of hospitalizations reported through IMPACT represents a subset of all influenza-associated paediatric hospitalizations in Canada. Delays in the reporting of data may cause data to change retrospectively.

Figure 7 - Text Description
Report week Influenza A Influenza B
35 0 0
36 0 0

Provincial/Territorial Influenza Hospitalizations and Deaths

In week 36, one laboratory-confirmed influenza-associated hospitalizations was reported from participating provinces and territoriesFootnote *.

Figure 8. Percentage of hospitalizations, ICU admissions and deaths with influenza reported by age-group, Canada 2015-16

Figure 8
Figure 8 - Text Description
Age-group (years) Hospitalizations (n=1) ICU admissions (n=0) Deaths (n=0)
0-4 0.0% 0.0% 0.0%
5-19 0.0% 0.0% 0.0%
20-44 0.0% 0.0% 0.0%
45-64 100.0% 0.0% 0.0%
65+ 0.0% 0.0% 0.0%

See additional data on Reported Influenza Hospitalizations and Deaths in Canada: 2009-10 to 2014-15 on the Public Health Agency of Canada website.

Influenza Strain Characterizations

The National Microbiology Laboratory (NML) has not yet reported any influenza strain characterizations for the 2015-16 season (Figure 9).

Figure 9. Influenza strain characterizations, Canada, 2015-16

The National Microbiology Laboratory (NML) has not yet conducted antigenic characterization of influenza viruses collected during the 2015-16 season.

The recommended components for the 2015-2016 northern hemisphere trivalent influenza vaccine include: an A/California/7/2009(H1N1)pdm09-like virus, an /Switzerland/9715293/2013(H3N2)-like virus, and a B/Phuket/3073/2013 -like virus (Yamagata lineage). For quadrivalent vaccines, the addition of a B/Brisbane/60/2008-like virus is recommended.

The NML receives a proportion of the number of influenza positive specimens from provincial laboratories for strain characterization and antiviral resistance testing. Characterization data reflect the results of haemagglutination inhibition (HAI) testing compared to the reference influenza strains recommended by WHO.

Antiviral Resistance

The NML has not yet reported antivirual resistance results for influenza viruses collected during the 2015-16 season (Table 2).

Table 2. Antiviral resistance by influenza virus type and subtype, Canada, 2015-16
Virus type and subtype Oseltamivir Zanamivir Amantadine
# tested # resistant (%) # tested # resistant (%) # tested # resistant (%)
A (H3N2) 0 0 0 0 0 0
A (H1N1) 0 0 0 0 0 0
B 0 0 0 0 NA Table 2 - Footnote * NA Table 2 - Footnote *
TOTAL 0 0 0 0 0 0
Table 2 - Footnote *

NA - not applicable

Return to Table 2 - Footnote * referrer

International Influenza Reports


FluWatch definitions for the 2015-2016 season

Abbreviations: Newfoundland/Labrador (NL), Prince Edward Island (PE), New Brunswick (NB), Nova Scotia (NS), Quebec (QC), Ontario (ON), Manitoba (MB), Saskatchewan (SK), Alberta (AB), British Columbia (BC), Yukon (YT), Northwest Territories (NT), Nunavut (NU).

Influenza-like-illness (ILI): Acute onset of respiratory illness with fever and cough and with one or more of the following - sore throat, arthralgia, myalgia, or prostration which is likely due to influenza. In children under 5, gastrointestinal symptoms may also be present. In patients under 5 or 65 and older, fever may not be prominent.

ILI/Influenza outbreaks

Schools:
Greater than 10% absenteeism (or absenteeism that is higher (e.g. >5-10%) than expected level as determined by school or public health authority) which is likely due to ILI.
Note: it is recommended that ILI school outbreaks be laboratory confirmed at the beginning of influenza season as it may be the first indication of community transmission in an area.
Hospitals and residential institutions:
two or more cases of ILI within a seven-day period, including at least one laboratory confirmed case. Institutional outbreaks should be reported within 24 hours of identification. Residential institutions include but not limited to long-term care facilities ( LTCF) and prisons.
Workplace:
Greater than 10% absenteeism on any day which is most likely due to ILI.
Other settings:
two or more cases of ILI within a seven-day period, including at least one laboratory confirmed case; i.e. closed communities.

Note that reporting of outbreaks of influenza/ILI from different types of facilities differs between jurisdictions.

Influenza/ILI activity level

1 = No activity: no laboratory-confirmed influenza detections in the reporting week, however, sporadically occurring ILI may be reported

2 = Sporadic: sporadically occurring ILI and lab confirmed influenza detection(s) with no outbreaks detected within the influenza surveillance region Footnote

3 = Localized:

  1. evidence of increased ILIFootnote * and
  2. lab confirmed influenza detection(s) together with
  3. outbreaks in schools, hospitals, residential institutions and/or other types of facilities occurring in less than 50% of the influenza surveillance regionFootnote

4 = Widespread:

  1. evidence of increased ILIFootnote * and
  2. lab confirmed influenza detection(s) together with
  3. outbreaks in schools, hospitals, residential institutions and/or other types of facilities occurring in greater than or equal to 50% of the influenza surveillance regionFootnote

Note: ILI data may be reported through sentinel physicians, emergency room visits or health line telephone calls.

Page details

Date modified: